¼¼°èÀÇ PCR °Ë»ç ¹× ½Ç½Ã°£ PCR °Ë»ç ½ÃÀå : ±âȸ ¹× Àü·«(-2033³â)
PCR And Realtime PCR Testing Global Market Opportunities And Strategies To 2033
»óǰÄÚµå : 1489308
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : 2024³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 327 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,000 £Ü 6,994,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,500 £Ü 10,491,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,989,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ PCR °Ë»ç ¹× ½Ç½Ã°£ PCR °Ë»ç ½ÃÀåÀº 2018³â¿¡ 108¾ï 3,574¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2023³â±îÁö ¿¬Æò±Õ -1.0% ÀÌ»óÀÇ CAGR·Î °¨¼ÒÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÇ·áºñ ÁöÃâ ±ÞÁõ

½ÇÀû ±â°£ µ¿¾È ÀÇ·áºñ ÁöÃâÀÇ ±Þ°ÝÇÑ Áõ°¡´Â PCR °Ë»ç ¹× ½Ç½Ã°£ PCR °Ë»ç ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇß½À´Ï´Ù. ÀÇ·á ÁöÃâ Áõ°¡´Â Á¶±â Áø´Ü ¹× Ä¡·á¸¦ °¡´ÉÇϰÔÇϰí, ȯÀÚ °ü¸®¸¦ °³¼±Çϰí, °øÁß º¸°Ç °á°ú¸¦ °³¼±Çϰí, PCR Å×½ºÆ® ¹× ½Ç½Ã°£ PCR Å×½ºÆ® ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇß½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 5¿ù ¿µ±¹ Á¤ºÎ ºÎóÀÎ ±¹°¡Åë°èû(Office for National Statistics)¿¡ µû¸£¸é ¿µ±¹ÀÇ ÀÇ·áºñ ÁöÃâÀº ¸í¸ñ ±âÁØ 9.4%, ½ÇÁú ±âÁØ 9.7% Áõ°¡ÇßÀ¸¸ç, 2021³â ¿µ±¹ÀÇ ÃÑ ÀÇ·áºñ ÁöÃâÀº 2,807¾ï ÆÄ¿îµå(3,672¾ï 5,000¸¸ ´Þ·¯), ÀǾàǰ ÁöÃâÀº 396¾ï 6,000¸¸ ÆÄ¿îµå(3,672¾ï 5,000¸¸ ´Þ·¯)), ÀǾàǰ ÁöÃâÀº 396¾ï ÆÄ¿îµå(518¾ï 4,000¸¸ ´Þ·¯)°¡ µÉ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ 2021³â ¿¹¹æ ÀÇ·á ÁöÃâÀº 351¾ï ÆÄ¿îµå(¹ÌÈ­ 459¾ï 3,000¸¸ ´Þ·¯)·Î Àü³â ´ëºñ 2¹è ÀÌ»ó Áõ°¡Çß½À´Ï´Ù. µû¶ó¼­ ÀÇ·á ÁöÃâÀÇ ±Þ°ÝÇÑ Áõ°¡´Â PCR °Ë»ç ¹× ½Ç½Ã°£ PCR °Ë»ç ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¸ñÂ÷

Á¦3Àå Ç¥ ¸®½ºÆ®

Á¦4Àå ±×·¡ÇÁ ¸®½ºÆ®

Á¦5Àå º¸°í¼­ ±¸¼º

Á¦6Àå ½ÃÀå Æ¯Â¡

Á¦7Àå ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦8Àå PCR °Ë»ç ¹× ½Ç½Ã°£ PCR °Ë»ç ½ÃÀå : °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦9Àå ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¼ºÀå

Á¦10Àå ¼¼°èÀÇ PCR °Ë»ç ¹× ½Ç½Ã°£ PCR °Ë»ç ½ÃÀå ¼¼ºÐÈ­

Á¦11Àå PCR °Ë»ç ¹× ½Ç½Ã°£ PCR °Ë»ç ½ÃÀå : Áö¿ª/±¹°¡º° ºÐ¼®

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦13Àå ¼­À¯·´ ½ÃÀå

Á¦14Àå µ¿À¯·´ ½ÃÀå

Á¦15Àå ºÏ¹Ì ½ÃÀå

Á¦16Àå ³²¹Ì ½ÃÀå

Á¦17Àå Áßµ¿ ½ÃÀå

Á¦18Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦19Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦20Àå °æÀï º¥Ä¡¸¶Å·

Á¦21Àå °æÀï ´ë½Ãº¸µå

Á¦22Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦23Àå ±âȸ¿Í Àü·«

Á¦24Àå PCR °Ë»ç ¹× ½Ç½Ã°£ PCR °Ë»ç ½ÃÀå : °á·Ð°ú Á¦¾È

Á¦25Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The polymerase chain reaction (PCR) and real-time polymerase chain reaction (RT-PCR) testing refers to pivotal technologies in molecular biology and diagnostics, widely used to amplify and quantify DNA and RNA sequences. These technologies serve a broad spectrum of users, from research scientists in academia and the biotechnology sector to medical professionals in clinical diagnostics. PCR and RT-PCR are essential tools in genetic research, forensic science and medical diagnostics, especially notable for their role in pathogen detection, including their significant use in COVID-19 testing.

The PCR and realtime PCR testing market consists of sales, by entities (organizations, sole traders and partnerships), of PCR and RT-PCR testing services that offer detection of genetic material from a specific organism, such as a virus.

The global PCR and realtime PCR testing market was valued at $10,835.74 million in 2018 which declined till 2023 at a compound annual growth rate (CAGR) of more than -1.0%.

Surge In Healthcare Expenditure

During the historic period, the surge in healthcare expenditure supported the growth of the PCR and realtime PCR testing market. Increased healthcare expenditure enabled early diagnosis and treatment, improved patient management and enhanced public health outcomes, driving the demand for PCR and real-time PCR testing services. For instance, in May 2023, according to the Office for National Statistics, a UK-based government department, healthcare spending in the UK increased by 9.4% in nominal terms and 9.7% in real terms. UK total healthcare expenditure in 2021 was £280.7 billion ($367.25 billion) and pharmaceutical expenditure was £39.6 billion ($51.84 billion) in 2021. Furthermore, spending on preventive care was £35.1 billion ($45.93 billion) in 2021, more than doubling from the previous year. Therefore, the surge in healthcare expenditure drove the growth of the PCR and realtime PCR testing market.

Strategic Collaborations And Partnerships Among Market Players

Major companies in the PCR and realtime PCR testing market are focusing on collaborations and partnerships to strengthen their market position, enhance product offerings and expand their geographic reach. Through these partnerships, companies can take advantage of emerging technologies, integrate complementary skills and reach emerging markets. For instance, in April 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, entered into a strategic partnership with GeneProof a.s., a Czech Republic-based biotechnology company. The partnership allows Thermo Fisher to broaden its PCR test menu by leveraging GeneProof's portfolio of 37 CE-IVD molecular diagnostic assays, enhancing the range of diagnostic solutions available to customers. For instance, in May 2022, Cipla Limited, an India-based pharmaceutical company, entered into a strategic partnership with Genes2Me Pvt. Ltd., an India-based molecular diagnostic company. The partnership between Cipla and Genes2Me for the COVID-19 RT PCR test kit brings advanced technology, faster testing, increased efficiency, Indian Council of Medical Research (ICMR) validation and expanded diagnostics offerings, contributing to improved COVID-19 testing capabilities in India.

The global PCR and realtime PCR testing market is fairly fragmented, with a large number of small players operating in the market. The top ten competitors in the market made up to 20.17% of the total market in 2022.

PCR And Realtime PCR Testing Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global PCR and realtime PCR testing market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Where is the largest and fastest-growing market for PCR and realtime PCR testing? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The PCR and realtime PCR testing market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider PCR and realtime PCR testing market; and compares it with other markets.

The report covers the following chapters

Markets Covered:

Table of Contents

1 Executive Summary

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

7 Major Market Trends

8 PCR And Realtime PCR Testing Market - Macro Economic Scenario

9 Global Market Size and Growth

10 Global PCR And Realtime PCR Testing Market Segmentation

11 PCR And Realtime PCR Testing Market, Regional and Country Analysis

12 Asia-Pacific Market

13 Western Europe Market

14 Eastern Europe Market

15 North America Market

16 South America Market

17 Middle East Market

18 Africa Market

19 Competitive Landscape And Company Profiles

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

23 Opportunities And Strategies

24 PCR And Realtime PCR Testing Market, Conclusions And Recommendations

25 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â